In the case of terminal Manα1-2 epitopes (Fig. 5c, d), we for instance only report an absolute decrease in lung cancer and chronic lymphocytic leukemia, after factoring in scale differences between conditions. The gene discussed is MAN2C1; the disease is lung carcinoma.